Can we measure it?
Define clinically meaningful adherence and assess validity, missingness, and burden. Engagement is not the same as following a prescription.
Research-led development · Statera Systems Inc.
Statera develops systems for support that stays within human authority. Our current focus is KeyRD: research and development into governed, auditable adaptive interventions and longitudinal dietary adherence.
A prototype and synthetic demonstrations exist.
Scientific validity, clinical benefit, and commercial viability remain to be established.
The governing idea
The control system
StateraContext · Permission · Boundaries · Evidence
Capability is not permission.
The company and the project
Statera Systems Inc. is the company developing and owning KeyRD. KeyRD is the current independent research and development project through which we are making the broader ideas testable.
The long-term aim is accountable delegated intelligence: actions that can be authorized, justified, challenged, stopped, and corrected. The immediate task is narrower: develop and verify useful components for dietary-adherence support, and work with collaborators to design studies of their feasibility and effects.
KeyRD today
When, for whom, and under what conditions does support help someone follow an RDN-defined dietary plan over time? When should the system remain quiet or return a decision to the RDN?
KeyRD includes implemented policy gates, source-bound plan interpretation, decision receipts and observation-recording components, alongside a separate protected professional-evaluation workflow and public synthetic demonstrations. Inspect component status and remaining work. The Maya demo illustrates a proposed six-week just-in-time adaptive intervention (JITAI) study.
The demo contains invented records. It does not run a trial, enroll participants, or establish that KeyRD improves adherence. Nothing is automatically sent to patients.
Explore the research agenda →Evidence before claims
Define clinically meaningful adherence and assess validity, missingness, and burden. Engagement is not the same as following a prescription.
Verify decision boundaries, reproducible records, assignment, and delivery before relying on them for research.
Design appropriate comparisons and longitudinal studies. Benefits, harms, and simpler alternatives all need consideration.
Research on professional nutrition care and digital support motivates these questions; it does not establish KeyRD’s effectiveness. Nutrition-care evidence · Digital-support evidence
Potential application
Potential routes include a standalone KeyRD offering, licensing components, joint development, or integration with existing research and care systems. These are possibilities to investigate, not launched products or confirmed partnerships. Demand, workflow fit, implementation cost, and a sustainable commercial model remain hypotheses.
Early-stage research funding could help test feasibility and technical merit. Any SBIR/STTR opportunity would require a suitable solicitation, confirmed eligibility, a qualified team, specific aims, milestones, and a credible commercialization rationale. No funding or agency endorsement is implied.
Who is accountable
Statera Systems Inc. was founded by Neil James.
James holds a BS in Nutrition & Food Science from LSU and completed the didactic program in dietetics. He is not an RDN. Clinical collaboration and independent review are being sought for the next stage. Statera is responsible for the system, its operating boundaries, and its claims.
This is founder-led independent research and development, with a commercial interest in KeyRD’s future use. No institutional affiliation, study approval, or validated scientific instrument is implied. The personal story belongs alongside the specific question on KeyRD’s site.
Why I’m working on KeyRD →Collaborate
Research collaborators can help shape a proposed study. Potential partners can examine a specific application. Start with the design and evidence, without patient records.